The purpose of this study was to develop and test a Clostridium difficile-associated disease (CDAD) grading system based on presenting symptoms in allogeneic stem cell transplant recipients. Patients with severe CDAD had significantly shorter median survival times and more adverse outcomes than patients with mild or moderate CDAD.

Original languageEnglish
Pages (from-to)208-211
Number of pages4
JournalInfection Control and Hospital Epidemiology
Issue number2
StatePublished - Feb 2007


Dive into the research topics of 'Severity of Clostridium difficile-associated disease (CDAD) in allogeneic stem cell transplant recipients: Evaluation of a CDAD severity grading system'. Together they form a unique fingerprint.

Cite this